[ad_1] Moderna stock fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings…
Read More »MRK
[ad_1] Moderna Inc. MRNA, -1.20% said Thursday it had net income of $1.465 billion, or $3.61 a share, in the…
Read More »[ad_1] Stocks that pay high dividends can provide comfort during times of market turmoil. It is much easier to be…
Read More »[ad_1] Moderna was rising Monday after an analyst at Jefferies upgraded the stock citing confidence in the vaccine maker’s growth…
Read More »[ad_1] Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA…
Read More »[ad_1] Moderna stock jumped by double digits Tuesday on positive news about the company’s cancer vaccine, but Chardan Capital Markets…
Read More »[ad_1] McCormick PulteGroup and Merck Merck were among the large U.S. companies that declared dividend increases this week. McCormick (ticker:MKC)…
Read More »[ad_1] Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20%…
Read More »